İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

MUSTAFA KARAAĞAÇ

DOÇENT

İSTİNYE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Onkoloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 92
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 15 Q2 12 Q3 32 Q4 13
WoS (JCR) Q1 5 Q2 8 Q3 17 Q4 39
TR Index 25 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 2
Ort. yüzdelik 44.5%
Üst %1 payı 0.0%
Üst %10 payı 2.5%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 92 yayın

Scopus (SJR)
Q1 15 Q2 12 Q3 32 Q4 13
WoS (JCR)
Q1 5 Q2 8 Q3 17 Q4 39
TR Index
25 makale

Makale listesi

  1. 2026 Prognostic Impact of the Systemic Immune-Inflammation Index According to Concurrent Chemotherapy Backbone in Stage III Non-Small Cell Lung Cancer Current Oncology DOI 10.3390/curroncol33070407 YÖKSİS SJR Q2 JCR Q2 OpenAlex 67.8%
  2. 2026 Efficacy and Tolerability of Pazopanib in Elderly Patients with Advanced Soft Tissue Sarcoma: A Multicentre Real-World Study from Turkey Journal of Clinical Medicine DOI 10.3390/jcm15124803 YÖKSİS SJR Q2 JCR Q1 OpenAlex 64.9%
  3. 2025 Clinical Outcomes of Adjuvant Chemotherapy in Elderly Patients with Resected Stage II and III Colon Cancer: A Real-life Data Osmangazi Tıp Dergisi DOI 10.20515/otd.1657501 YÖKSİS TR Index
  4. 2024 The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing Journal of Chemotherapy DOI 10.1080/1120009X.2024.2305066 YÖKSİS SJR Q3 JCR Q3 OpenAlex 58.4%
  5. 2024 Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience Medicina DOI 10.3390/medicina60050818 YÖKSİS SJR Q2 JCR Q1 OpenAlex 59.3%
  6. 2024 A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy MEDICINE DOI 10.1097/MD.0000000000037972 YÖKSİS SJR Q3 JCR Q2 OpenAlex 65.6%
  7. 2023 Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC? Journal of Cancer Research and Clinical Oncology DOI 10.1007/s00432-023-05190-3 YÖKSİS SJR Q1 JCR Q3 OpenAlex 49.6%
  8. 2023 The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer Medknow DOI 10.4103/jcrt.jcrt_1657_21 YÖKSİS SJR Q3 JCR Q4 OpenAlex 55.2%
  9. 2023 Sunitinib-induced small bowel wall edema as a prognostic marker in metastatic renal cell carcinoma Medknow DOI 10.4103/jcrt.jcrt_899_21 YÖKSİS SJR Q3 JCR Q4 OpenAlex 44.6%
  10. 2023 Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy? Springer Science and Business Media LLC DOI 10.1007/s12029-023-00972-x YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.6%
  11. 2023 Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study Springer Science and Business Media LLC DOI 10.1007/s00432-023-04766-3 YÖKSİS SJR Q1 JCR Q3 OpenAlex 80.2%
  12. 2023 Low-dose (7.5 mg/kg) bevacizumab may be a viable option in recurrent ovarian cancer: A retrospective study. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS DOI 10.4103/jcrt.jcrt_1879_20 YÖKSİS SJR Q3 JCR Q4 OpenAlex 59.8%
  13. 2023 The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study Journal of Cancer Research and Clinical Oncology DOI 10.1007/s00432-023-04628-y. YÖKSİS SJR Q1 JCR Q3 OpenAlex 36.5%
  14. 2023 Major and minor salivary gland cancers: A multicenter retrospective study HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK DOI 10.1002/hed.27376. YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.5%
  15. 2023 Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy BMC Cancer DOI 10.1186/s12885-023-10609-8 YÖKSİS OpenAlex üst %10 OpenAlex 94.2%
  16. 2023 Where Should Enzalutamide Be in The Metastatic Castration Resistant Prostate Cancer (mCRPC): A Multi-center Study Eurasian Journal of Medicine and Oncology DOI 10.14744/ejmo.2023.69719 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 4.4%
  17. 2023 A new prognostic factor in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan: Hemoglobin, albumin, lymphocytes and platelets (HALP) score Archives of Current Medical Research DOI 10.47482/acmr.1175461 YÖKSİS TR Index OpenAlex 44.9%
  18. 2023 Otuz yaş altı meme kanserli kadınların klinikopatolojik özellikleri ve sağkalım sonuçları Akdeniz Medical Journal DOI 10.53394/akd.979443 YÖKSİS TR Index OpenAlex 4.3%
  19. 2022 Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer JOURNAL OF ONCOLOGY PHARMACY PRACTICE DOI 10.1177/10781552211066073 YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.8%
  20. 2022 First renal metastasis report from tongue cancer Brazilian Journal of Otorhinolaryngology DOI 10.1016/j.bjorl.2021.03.007 YÖKSİS SJR Q2 JCR Q2 OpenAlex 4.5%

Akademisyenlere dön